Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01131806 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

124

Enrollment

OTHER_GOV

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: fluticasone/ salmeterol 125/25 mcg/puff
DRUG: fluticasone/ salmeterol 250/25 mcg/puff

Sponsor

Taipei Veterans General Hospital, Taiwan

Collaborators

[object Object]
[object Object]